2018 Korean Heart Rhythm Society Guidelines for Non-Vitamin K Antagonist Oral Anticoagulants
- Author:
Yae Min PARK
1
;
Hyung Wook PARK
;
Jung Myung LEE
;
Jin Kyu PARK
;
Ki Hong LEE
;
Jin Bae KIM
;
Young Soo LEE
;
Boyoung JOUNG
Author Information
- Publication Type:Review
- Keywords: Atrial fibrillation; Non-vitamin K antagonist oral anticoagulants; Guideline
- MeSH: Anticoagulants; Atrial Fibrillation; Coronary Artery Disease; Electric Countershock; Heart; Humans; Korea; Stroke; Vitamin K
- From:Korean Journal of Medicine 2019;94(1):57-82
- CountryRepublic of Korea
- Language:Korean
- Abstract: Non-vitamin K antagonist oral anticoagulants (NOACs) are an alternative to vitamin K antagonists (VKAs) and have emerged as the treatment of choice in Korea. However, several questions remain regarding the optimal use of these agents in specific clinical situations. In this paper we discuss 1) patients with atrial fibrillation (AF) and coronary artery disease, 2) avoiding confusion with NOAC dosing across indications, 3) cardioversion in a patient treated with a NOAC, 4) AF patients who present with acute stroke while on NOACs, 5) NOACs in special situations, 6) anticoagulation in AF patients with a malignancy, and 7) optimizing VKA dose adjustments.
